“as well as evaluating the feasibility and timelines for the HIV BLA resubmission and explore other cancer and immunologic indications for leronlimab.”

Why is this still mentioned? Do we really think we can submit the BLA. This would be even better news then a partnership or even any buyout imo. But does anyone honestly believe this is even possible?

Ohm If you don’t mind commenting I’d appreciate your opinion or anyone else for that matter.